The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Clozapine promotes the reaction [Raclopride promotes the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]]; Raclopride inhibits the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]; Raclopride promotes the reaction [Dopamine promotes the reaction [AGT protein results in increased secretion of Aldosterone]]
Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]
[Dopamine co-treated with Raclopride] promotes the reaction [Dopamine binds to DRD2 protein]; Cocaine affects the reaction [Raclopride binds to DRD2] Raclopride binds to DRD2; Raclopride binds to DRD2 protein DRD2 protein alternative form results in increased susceptibility to Raclopride Raclopride binds to DRD2 protein; Raclopride binds to DRD2 protein alternative form Amlodipine inhibits the reaction [Raclopride binds to DRD2 protein]; bisphenol A promotes the reaction [Raclopride binds to DRD2 protein]; Diltiazem inhibits the reaction [Raclopride binds to DRD2 protein]; Flunarizine inhibits the reaction [Raclopride binds to DRD2 protein]; manidipine inhibits the reaction [Raclopride binds to DRD2 protein]; Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]; Verapamil inhibits the reaction [Raclopride binds to DRD2 protein] [Raclopride binds to and results in decreased activity of DRD2 protein] which results in decreased susceptibility to Methylphenidate; [Raclopride binds to and results in decreased activity of DRD2 protein] which results in decreased susceptibility to Nicotine; [Raclopride binds to and results in decreased activity of DRD2 protein] which results in increased abundance of Dopamine; DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein]; DRD2 protein affects the reaction [Raclopride results in increased expression of GSK3A protein]; Raclopride binds to and results in decreased activity of DRD2 protein; Saponins inhibits the reaction [Raclopride binds to DRD2 protein]
[Raclopride binds to and results in decreased activity of DRD3 protein] which results in increased abundance of Dopamine; Raclopride binds to and results in decreased activity of DRD3 protein